Geode Capital Management, LLC Burning Rock Biotech LTD Transaction History

Geode Capital Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$2.16 - $3.47 $15,791 - $25,369	7,311 Added 39.97%	25,600 $71,000
Q4 2022 Feb 13, 2023	SELL	$1.73 - $2.95 $15,153 - $25,839	-8,759 Reduced 32.38%	18,289 $41,000
Q2 2022 Aug 12, 2022	SELL	$1.75 - $10.44 $64,366 - $383,993	-36,781 Reduced 57.62%	27,048 $78,000
Q1 2022 May 13, 2022	SELL	$6.7 - $10.23 $2,680 - $4,092	-400 Reduced 0.62%	63,829 $592,000
Q4 2021 Feb 11, 2022	SELL	$9.43 - $17.14 $1.05 Million - $1.91 Million	-111,192 Reduced 63.39%	64,229 $612,000
Q3 2021 Nov 12, 2021	BUY	$17.37 - $27.92 $168,992 - $271,633	9,729 Added 5.87%	175,421 $3.11 Million
Q2 2021 Aug 13, 2021	BUY	$26.14 - $37.45 $3.74 Million - $5.35 Million	142,909 Added 627.26%	165,692 $4.84 Million
Q1 2021 May 12, 2021	BUY	$23.5 - $39.58 $535,400 - $901,751	22,783 New	22,783 $613,000
Q3 2020 Nov 13, 2020	SELL	$19.07 - $29.61 $141,423 - $219,587	-7,416 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$23.21 - $31.43 $172,125 - $233,084	7,416 New	7,416 $200,000

21.2K

Ticker BNR
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 105,188,000
Market Cap $721M
Description
Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based cancer therapy selection and p...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.